Pharma companies represent 36.5% of end user demand, sugar spheres (nonpareils) account for 36.6% of core substrate sales and 0.1-0.3 mm holds 29.2% within the particle size segment in 2026. The pharma-grade dummy pellets market was valued at USD 480.0 million in 2025 and is forecast to post a 6.7% CAGR between 2026 and 2036.